CRT PREDICTS | CHIP-BCIS3

Sunday, March 8, 2026

11:00 AM - 11:20 AM EST

Location: Spotlight Theater

Moderator(s)

Gregg W. Stone, MD, FACC, MSCAI

Physician
Mount Sinai
New York, New York, United States

Disclosure(s): Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter, Vascentis: Stock-privately held company (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Consulting Fees (e.g., advisory boards) (Terminated); Colibri, Remote Cardiac Enablement, Valfix, Zoll, HeartFlow, Shockwave, Ancora, Adona Medical, Abbott, HighLife, Elucid Bio, Aria, Alleviant, FBR Medical, Bioventrix, MedHub, Biotyx Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave, Biosense-Webster, Bioventrix, Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Pulnovo, V-wave and PCORI via Weill Cornell Medical Center.: Grant/Research Support (Ongoing)

Panel Discussant(s)

Sripal Bangalore, MD, MHA, FACC, FAHA, FSCAI

Professor of Medicine
New York University School of Medicine
New York University School of Medicine
New York, New York, United States

Disclosure(s): Abbott Vascular, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing); Jupiter Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Stryker: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
David Cox, MD, MSCAI

Interventional Cardiologist
Sanger HVI Charlotte NC
Charlotte, North Carolina, United States

Disclosure(s): No financial relationships to disclose
Jeffrey W. Moses, MD, FSCAI

John and Myrna Daniels Professor of Cardiology
Columbia University Medical Center
New York, New York, United States

Disclosure(s): Abiomed (spouse): Consulting Fees (e.g., advisory boards) (Ongoing); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stock Options [in privately held companies] (Ongoing); Covanos: Stock Options [in privately held companies] (Ongoing); seimens: Consulting Fees (e.g., advisory boards) (Ongoing); Weightless Lead: Stock-privately held company (Ongoing)
David G. Rizik, MD, MSCAI, FACC

Health System Chief of Cardiovascular Service Line, Physician Executive Community Cardiovascular Research
Banner University Medicine, Scottsdale Arizona
Scottsdale, Arizona, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Gregg W. Stone, MD, FACC, MSCAI: Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter, Vascentis: Stock-privately held company (Ongoing); Cardiac Success, Occlutech, Ablative Solutions, Oxitope, Elixir, Impulse Dynamics, Asceneuron, Myochron, Vesalio: Consulting Fees (e.g., advisory boards) (Terminated); Colibri, Remote Cardiac Enablement, Valfix, Zoll, HeartFlow, Shockwave, Ancora, Adona Medical, Abbott, HighLife, Elucid Bio, Aria, Alleviant, FBR Medical, Bioventrix, MedHub, Biotyx Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave, Biosense-Webster, Bioventrix, Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Pulnovo, V-wave and PCORI via Weill Cornell Medical Center.: Grant/Research Support (Ongoing)

Sripal Bangalore, MD, MHA, FACC, FAHA, FSCAI: Abbott Vascular, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing); Jupiter Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Stryker: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

David Cox, MD, MSCAI: No financial relationships to disclose

Jeffrey W. Moses, MD, FSCAI: Abiomed (spouse): Consulting Fees (e.g., advisory boards) (Ongoing); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stock Options [in privately held companies] (Ongoing); Covanos: Stock Options [in privately held companies] (Ongoing); seimens: Consulting Fees (e.g., advisory boards) (Ongoing); Weightless Lead: Stock-privately held company (Ongoing)

David G. Rizik, MD, MSCAI, FACC: No financial relationships to disclose